Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Pacira BioSciences, Inc.(PCRX) Shareholders
Levi &Korsinsky, LLP notifies investors in Pacira BioSciences, Inc. (“Pacira” or the “Company”) (NASDAQ: PCRX) of a class action securities lawsuit. https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Pacira investors who were adversely affected by alleged securities fraud between August 2, 2023 and August 8, 2024. Follow the link below […]